Founded in 2010 and headquartered in Paris with offices in Alsace (France) and Massachusetts (USA).
Specializes in the development of drugs and medical devices.
Extensive experience with more than 100 products and 600 pre-clinical & clinical trials in many therapeutic areas including CNS, pain, inflammation, metabolic disorders, auto-immune disorders, pulmonary, cardiovascular, and orphan drugs.
Collaboration with several academic research centers, start-up and mid-size biotechnology companies, venture capitalist firms and pharmaceutical companies.
Committed to bring to our clients customized approach and tailored solutions.
Provides scientific multi-disciplinary, complementary expertise, and specific tools to identify the best approach to move the R&D projects quickly through regulatory development.
Deep knowledge in translational medicine, proof of concept studies and clinical development plans that offer the most appropriate interface between fundamental and applied research.
Delivers innovative approaches to financing projects throughout their life cycle (initial due diligence, grants, technical support in discussions with financial and trade partners).
Combines complementary expertise of many years working in drug & device development to provide comprehensive, optimized and integrated preclinical and clinical services with a trusted network of contractors.
12, Rue de la Paix
75 002 PARIS
PPRS French Office
4E, Avenue du Général de Gaulle
68 000 COLMAR
Phone: +33 (0)3 89 24 16 86
PPRS US Office
271 Pepperell RD
Groton, MA 01450
Phone: +1 781 467 9115
Copyright | PPRS SAS | RCS Paris B 529 166 977
Site owner : PPRS SAS (private limited company) with a capital of 40 000,00 € - 12 Rue de la Paix - 75002 PARIS
PPRS SAS is registered on the "Registre du commerce et des sociétés" (Trade and Companies Register) under number 529 166 977 RCS Paris B
Publication director : Fabrice AUROUSSEAU - president of PPRS SAS
Hosted by PlanetHoster - 4416 Louis-B.-Mayer - Québec - CANADA
By continuing your navigation, you accept the use of third-party services that may install cookies.AcceptDeclineRead more